APA

Arif S., Gomez-Tourino I., Kamra Y., Pujol-Autonell I., Hanton E., Tree T., Melandri D., Hull C., Wherrett D. K., Beam C., Roep B. O., Lorenc A. & Peakman M. (20210929). GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. : Diabetologia.

Chicago

Arif Sefina, Gomez-Tourino Iria, Kamra Yogesh, Pujol-Autonell Irma, Hanton Emily, Tree Timothy, Melandri Daisy, Hull Caroline, Wherrett Diane K, Beam Craig, Roep Bart O, Lorenc Anna and Peakman Mark. 20210929. GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. : Diabetologia.

Harvard

Arif S., Gomez-Tourino I., Kamra Y., Pujol-Autonell I., Hanton E., Tree T., Melandri D., Hull C., Wherrett D. K., Beam C., Roep B. O., Lorenc A. and Peakman M. (20210929). GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. : Diabetologia.

MLA

Arif Sefina, Gomez-Tourino Iria, Kamra Yogesh, Pujol-Autonell Irma, Hanton Emily, Tree Timothy, Melandri Daisy, Hull Caroline, Wherrett Diane K, Beam Craig, Roep Bart O, Lorenc Anna and Peakman Mark. GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. : Diabetologia. 20210929.